Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24


Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial.

He M, Li Q, Zou R, Shen J, Fang W, Tan G, Zhou Y, Wu X, Xu L, Wei W, Le Y, Zhou Z, Zhao M, Guo Y, Guo R, Chen M, Shi M.

JAMA Oncol. 2019 May 9. doi: 10.1001/jamaoncol.2019.0250. [Epub ahead of print]


Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.

Yang Z, Zou R, Zheng Y, Qiu J, Shen J, Liao Y, Zhang Y, Wang C, Wang Y, Yuan Y, Li K, Zuo D, He W, Liu W, Li B, Yuan Y.

Eur Radiol. 2019 Apr 16. doi: 10.1007/s00330-019-06157-0. [Epub ahead of print]


Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy.

Wang Y, Sun K, Shen J, Li B, Kuang M, Cao Q, Peng S.

Cancer Res Treat. 2019 Mar 11. doi: 10.4143/crt.2018.657. [Epub ahead of print]


Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib.

Shen L, Xi M, Zhao L, Zhang X, Wang X, Huang Z, Chen Q, Zhang T, Shen J, Liu M, Huang J.

Cancers (Basel). 2018 Dec 14;10(12). pii: E516. doi: 10.3390/cancers10120516.


Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation.

Liu W, Zheng Y, Zou R, Shen J, He W, Yang Z, Zhang Y, Li B, Yuan Y.

BMC Cancer. 2018 Nov 29;18(1):1186. doi: 10.1186/s12885-018-5069-z.


Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation.

Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhang Y, Chen M.

Cancers (Basel). 2018 Oct 10;10(10). pii: E378. doi: 10.3390/cancers10100378.


Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies.

Zhou S, Liu S, Zhang L, Guo S, Shen J, Li Q, Yang H, Feng Y, Liu M, Lin SH, Xi M.

Ann Surg Oncol. 2018 Nov;25(12):3639-3646. doi: 10.1245/s10434-018-6736-7. Epub 2018 Sep 7.


Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence.

Tao Q, He W, Li B, Zheng Y, Zou R, Shen J, Liu W, Zhang Y, Yuan Y.

J Cancer. 2018 Jul 16;9(16):2778-2785. doi: 10.7150/jca.25033. eCollection 2018.


Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.

Liu W, Zheng Y, He W, Zou R, Qiu J, Shen J, Yang Z, Zhang Y, Wang C, Wang Y, Zuo D, Li B, Yuan Y.

Aliment Pharmacol Ther. 2018 Sep;48(6):671-681. doi: 10.1111/apt.14929. Epub 2018 Jul 31.


Failure pattern of elective nodal irradiation for esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy.

Zhou S, Zhang L, Luo L, Li Q, Shen J, Feng Z, Feng Y, Yang H, Liu M, Xi M.

Jpn J Clin Oncol. 2018 Sep 1;48(9):815-821. doi: 10.1093/jjco/hyy099.


Diagnostic value of intraoperative ultrasonography in assessing thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer.

Wang J, Liu M, Shen J, Ouyang H, Xie X, Lin T, Li A, Yang H.

BMC Cancer. 2018 Jul 13;18(1):737. doi: 10.1186/s12885-018-4643-8.


Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study.

He W, Zheng Y, Zou R, Shen J, Yang J, Qiu J, Tao Q, Liu W, Yang Z, Zhang Y, Li B, Yuan Y.

Cancer Commun (Lond). 2018 May 21;38(1):26. doi: 10.1186/s40880-018-0296-x.


Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery.

He W, Peng B, Tang Y, Yang J, Zheng Y, Qiu J, Zou R, Shen J, Li B, Yuan Y.

Clin Gastroenterol Hepatol. 2018 May;16(5):756-764.e10. doi: 10.1016/j.cgh.2017.12.002. Epub 2017 Dec 12.


Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence.

Liao Y, Zheng Y, He W, Li Q, Shen J, Hong J, Zou R, Qiu J, Li B, Yuan Y.

Oncol Lett. 2017 Feb;13(2):984-992. doi: 10.3892/ol.2016.5525. Epub 2016 Dec 20.


Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.

He W, Li B, Zheng Y, Zou R, Shen J, Cheng D, Tao Q, Liu W, Li Q, Chen G, Yuan Y.

Liver Int. 2016 Nov;36(11):1677-1687. doi: 10.1111/liv.13166. Epub 2016 Jun 3.


Small cell carcinoma of the rectum: A report of imaging results from four cases.

Zhou J, Shen J, Ma H, Zhang Y, Sun M, Zheng L, Lv Y.

Oncol Lett. 2016 Mar;11(3):1671-1676. Epub 2016 Jan 20.


Low-Grade and High-Grade Mucoepidermoid Carcinoma of the Lung: CT Findings and Clinical Features of 17 Cases.

Wang YQ, Mo YX, Li S, Luo RZ, Mao SY, Shen JX.

AJR Am J Roentgenol. 2015 Dec;205(6):1160-6. doi: 10.2214/AJR.14.14153.


Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.

Qiu J, Zheng Y, Shen J, Zeng QA, Zou R, Liao Y, He W, Li Q, Chen G, Li B, Yuan Y.

Surgery. 2015 Nov;158(5):1235-43. doi: 10.1016/j.surg.2015.04.002. Epub 2015 May 7.


The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis.

He W, Zeng Q, Zheng Y, Chen M, Shen J, Qiu J, Chen M, Zou R, Liao Y, Li Q, Wu X, Li B, Yuan Y.

BMC Cancer. 2015 Apr 11;15:263. doi: 10.1186/s12885-015-1280-3.


Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical Trial.

Wu X, Li B, Qiu J, Shen J, Zheng Y, Li Q, Liao Y, He W, Zou R, Yuan Y.

J Clin Gastroenterol. 2015 Jul;49(6):520-8. doi: 10.1097/MCG.0000000000000277.


Supplemental Content

Loading ...
Support Center